Escolar Documentos
Profissional Documentos
Cultura Documentos
528534
0095-1137/95/$04.0010
Copyright q 1995, American Society for Microbiology
We assessed the capacity of three DNA typing techniques to discriminate between 81 geographically,
temporally, and epidemiologically unrelated strains of Pseudomonas aeruginosa. The methods, representing
powerful tools for hospital molecular epidemiology, included hybridization of restricted chromosomal DNA
with toxA and genes coding for rRNA (rDNA) used as probes and macrorestriction analysis of SpeI-digested
DNA by pulsed-field gel electrophoresis. The probe typing techniques were able to classify all strains into a
limited number of types, and the discriminatory powers were 97.7 and 95.6% for toxA and rDNA typing,
respectively. Strains that were indistinguishable on the basis of both toxA and rDNA types defined 12 probe
type homology groups. Of these, one contained five strains, three contained three strains each, and eight groups
were represented by two strains each. Strains in 10 of the homology groups had the same O serotype. SpeI
macrorestriction patterns discriminated between all strains with at least four band differences, which corresponded to a similarity level of 85%. Fifteen pairs of strains were similar at a level of >75% and differed by only
four to seven bands. Of these pairs, 11 belonged to the same probe type homology group, indicating their clonal
relatedness. We conclude that macrorestriction analysis of P. aeruginosa with SpeI provides the best means of
discrimination between epidemiologically unrelated strains. However, DNA probe typing with either toxA or
rDNA reveals information on the strain population structure and evolutionary relationships.
hybridization to specific gene probes or may be generated a
priori by rarely cutting restriction enzymes. Both approaches
are currently employed for P. aeruginosa in epidemiological
investigations (8, 22). Gene probes available for this purpose
either hybridize to species-specific coding regions (20, 30) or
are more broadly applicable, such as Escherichia coli genes
coding for rRNA (rDNA) which hybridize to repetitive rDNA
operons of a large number of bacteria (ribotyping) (15, 32).
Resolution of large DNA fragments (macrorestriction analysis) is accomplished by pulsed-field gel electrophoresis techniques, such as field inversion gel electrophoresis and contourclamped homogeneous electric field (CHEF) electrophoresis
(8). These techniques identify variations in the electrophoretic
mobilities of large restriction fragments and avoid the need for
hybridization with previously labeled DNA probes.
Recently, a multicenter international trial for the typing of
P. aeruginosa compared phenotypic and genotypic methods
principally for their reproducibility with sets of isolates predominantly from cystic fibrosis patients (13). However, it was
not possible in that study to address the key issue of the ability
of novel genetic methods such as pulsed-field gel electrophoresis and use of universal (rDNA) and specific (toxA) probes to
distinguish unequivocally between clearly distinct strain populations.
The purpose of the current investigation was to test three
established DNA-based typing techniques for P. aeruginosa in
parallel by a blinded design to determine the discriminatory
power and reproducibility and, moreover, to provide empirically based guidelines for the interpretation of results obtained
by these methods.
528
RESULTS
toxA typing. All strains of P. aeruginosa showed a toxAreactive fragment pattern. Hybridization with the toxA probe
produced 10, 13, and 29 different fragment patterns after restriction digestion with BglII, SalI, and XhoI, respectively. Each
pattern consisted of one to four bands and comprised variable
as well as constant fragments. For four isolates, the constant
fragments were missing after restriction digestion with any of
529
530
J. CLIN. MICROBIOL.
GRUNDMANN ET AL.
TABLE 1. Origins of P. aeruginosa strains and typing results
DNA typing pattern
Strain code
4587
4785
5072
5670
5757
6338
6563
6582
6666
6734
6898
6920
6950
6954
6973
6992
7027
7083
7186
7193
7215
7256
7272
7306
7336
7433
7464
7622
7627
7726
7790
7793
7819
7868
7874
7916
7948
8045
8049
8101
8103
8113
8122
8131
8159
8166
8184
8188
8202
8212
8214
8237
8238
8277
8297
8314
8318
8321
8357
8362
8364
8375
8382
8386
8390
8400
8405
Boston, UK
Kings College
Charing
Scunthorpe, UK
Toulouse, France
Studi
Blackburn, UK
Spain
Birmingham, UK
Austria
Royal Free
Worthing, UK
Southport, UK
Glasgow, UK
Slovenia
Netherlands
Hong Kong
Bury, UK
Truro, UK
Milton Keynes
Bath, UK
Hammersmith
Cumbria, UK
Queen Elizabeth II
Oxford, UK
Leicester, UK
Leeds, UK
Coventry, UK
Croydon, UK
Sheffield, UK
Nuneaton, UK
Tyne & Wear, UK
Whitechapel
Winchester, UK
West Yorkshire, UK
Bristol, UK
Durham, UK
Norwich, UK
Pilgrim
Stourbridge, UK
St. Marys
Conquest
Mid-glamorgan
Hull, UK
Italy
Redditch, UK
Queen Marys
Grantham, UK
St. Thomas
Clwyd, UK
Llanelli
St. Barts
Park Royal, UK
Durham, UK
Portsmouth, UK
Southhampton, UK
Sutton, UK
Edmonton, UK
Plymouth, UK
St. Georges
University College
Gt. Ormond
Whippscross
Wexham, UK
North Devonshire
New Cross
Bangor, UK
Serotype
II
4
3
II
1
12
3
II
9
1
II
10
12
4
6
6
11
1
II
4
11
6
6
6
6
1
11
6
4
II
9
1
6
11
3
II
11
6
II
11
3
II
1
II
11
9
II
3
10
3
6
10
4
1
11
3
6
II
II
3
3
11
10
1
8
10
8
toxA typea
rDNA type
PTHG
PFGEb
10.08.09 T14
04.06.11 T10
01.11.23 T3
10.08.04 T16
01.01.01 T1
02.02.02 T17
01.01.01 T1
01.01.03 T8
03.01.01 T9
01.01.01 T1
04.02.04 T18
05.03.05 T2
06.04.00 T4
04.06.11 T10
01.07.07 T19
06.02.08 T20
05.08.05 T2
08.08.09 T21
04.08.10 T5
09.08.11 T22
05.03.05 T2
06.02.12 T23
04.08.05 T24
06.09.13 T25
06.03.14 T11
03.10.15 T12
07.06.16 T26
07.11.07 T3
01.01.01 T1
09.02.18 T27
01.11.19 T28
03.01.20 T29
04.06.11 T6
02.11.17 T30
07.03.22 T31
10.08.10 T13
10.08.17 T7
06.08.23 T32
11.14.29 T33
10.08.17 T7
07.08.17 T34
10.08.09 T4
03.10.15 T12
06.03.09 T35
05.03.05 T2
03.01.01 T9
04.08.10 T5
07.11.17 T3
05.03.05 T2
Atyp 1 T46
Atyp 2 T47
05.03.05 T2
01.01.01 T1
01.01.01 T1
10.08.17 T7
01.01.24 T36
01.01.23 T3
04.08.11 T5
10.02.10 T13
03.11.23 T37
01.02.18 T38
03.02.17 T39
05.03.05 T2
09.11.10 T40
Atyp 3 T48
01.01.01 T1
Atyp 4 T49
R6
R7
R6
R13
R8
R9
R20
R14
R2
R4
R13
R3
R10
R7
R21
R2
R11
R11
R5
R4
R3
R2
R22
R15
R1
R2
R16
R1
R9
R7
R23
R1
R24
R1
R2
R17
R25
R1
R11
R18
R1
R6
R2
R26
R27
R2
R5
R28
R3
R12
R29
R3
R12
R8
R18
R9
R1
R5
R5
R4
R1
R30
R3
R1
R4
R31
R12
5
6
13
14
2
15
16
17
7
18
19
1
3
6
20
21
22
23
4
24
1
25
26
27
9
8
28
10
29
30
31
32
33
34
35
36
37
38
39
11
40
5
8
41
42
7
4
43
1
44
45
1
46
2
11
47
10
4
48
49
50
51
1
52
53
54
55
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Untyp.d
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
Untyp.
56
57
58
59
60
61
62
63
64
65
531
TABLE 1Continued
DNA typing pattern
Strain code
8414
8420
8440
8623
8722
8723
8734
8735
8756
8757
292
9721
15442
27853
Serotype
Newcastle, UK
Hope, UK
Carmarthen, UK
High Wycombe, UK
Belfast, UK
Harold Wood, UK
Stoke/Trent
Birmingham, UK
France
Newcastle, UK
ATCC
ATCC
ATCC
ATCC
toxA typea
6
1
6
PAe
12
3
6
1
12
9
11
6
1
6
01.01.03
01.13.15
10.08.03
07.06.06
06.04.00
07.06.06
06.03.14
01.01.01
06.04.00
06.03.09
04.01.26
07.11.27
01.13.15
06.12.28
T8
T15
T41
T6
T4
T6
T11
T1
T4
T42
T43
T4
T1
T45
rDNA type
PTHG
PFGEb
R2
R14
R17
R19
R10
R19
R1
R8
R10
R32
R16
R1
R2
R15
56
57
58
12
3
12
9
2
3
59
60
61
62
63
66
67
68
Untyp.
69
70
71
72
73
Untyp.
74
75
76
77
a
Numbers separated by periods indicate fragment patterns generated by enzymes BglI, SalI, and XhoI, respectively. Atyp 1 through 4, restriction patterns lacking
conserved fragments.
b
PFGE, pulsed-field gel electrophoresis type.
c
UK, United Kingdom.
d
Untyp., untypeable.
e
PA, polyagglutinable.
strains into a limited number of types and when used alone are
able to identify similarities between strains. However, it is
often necessary to combine methods such as O serotyping with
phage typing or to add bacteriocin typing in order to obtain
maximal discrimination between apparently related strains.
The reproducibility of phage typing, in particular, is poor (5,
13), and that of bacteriocin typing may be inadequate for some
strains, such as those from cystic fibrosis patients (6, 13).
Chromosomal fingerprinting with DNA probes or macrorestriction analysis by pulsed-field gel electrophoresis has been
successfully applied to the subtyping of P. aeruginosa (8, 31).
An array of different probes has been proposed so far. They
include virulence genes such as the 39 pilin coding region from
strain PAK (30), toxA (21), algD and lasA (17), and plcSR (34)
and a broad-spectrum probe of E. coli rDNA (for ribotyping)
No. of strains
T1
T2
T3
T4
T5
T6
T7
T8
T9
T10
T11
T12
T13
T14
T15
T16T49
8
7
4
3
3
3
3
2
2
2
2
2
2
2
2
1b
Total
81
Frequency (%)
9.88
8.64
4.94
3.70
3.70
3.70
3.70
2.47
2.47
2.47
2.47
2.47
2.47
2.47
2.47
1.23c
100
(1, 7, 9, 10). Only recently, some of these techniques, phenotypical as well as DNA-based methods, have been critically
evaluated (13). However, strains investigated in that study
were mainly from cystic fibrosis patients and thus cannot be
regarded as representative of epidemiologically unrelated hospital strains.
We set out to assess the discriminatory capacity of the currently most successful DNA fingerprinting techniques for P.
aeruginosa (7, 13, 28) and chose toxA and rDNA typing as well
as SpeI macrorestriction analysis for comparison. All three
methods had never before been tested in parallel on a large
panel of unrelated strains.
TABLE 3. Frequency of rDNA types among epidemiologically
unrelated strains of P. aeruginosaa
rDNA type(s)
No. of strains
Frequency (%)
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20R32
11
9
5
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1b
13.58
11.11
6.17
4.94
4.94
3.70
3.70
3.70
3.70
3.70
3.70
3.70
2.47
2.47
2.47
2.47
2.47
2.47
2.47
1.23c
Total
81
100
532
GRUNDMANN ET AL.
J. CLIN. MICROBIOL.
TABLE 5. IATSa serotypes and macrorestriction analysis of P.
aeruginosa strains from the same PTHG
1 (T2 R3)
2 (T1 R8)
3 (T4 R10)
4 (T5 R5)
5 (T14 R6)
6 (T10 R7)
7 (T9 R2)
8 (T12 R2)
9 (T11 R1)
10 (T3 R1)
11 (T7 R18)
12 (T6 R19)
1363
Total
No. of strains
5
3
3
3
2
2
2
2
2
2
2
2
1b
81
Frequency (%)
6.17
3.70
3.70
3.70
2.47
2.47
2.47
2.47
2.47
2.47
2.47
2.47
1.23c
PTHG
6920
6920
7215
8202
8237
8382
10
11
10
10
10
II
5757
5757
8277
8735
1
1
1
III
100
O serotype
6950
6950
8722
8756
Strain
12
12
12
IV
7186
7186
8184
8321
II
II
II
4587
4587
8113
II
II
4785
4
4
6666
8166
9
9
6666
7433
1
1
7336
6
6
8101
7622
8318
6
6
7622
74.1
70.9
55.2
75.4
8277
8735
79.6
86.4
84.4
8722
8756
84.9
55.6
83.9
8184
8321
84.0
85.7
81.1
8113
6954
8166
8122
8734
8297
8318
Untyp.c
Untyp.
XII
8623
PA
3
81.0
85.4
70.1
66.0
XI
8623
8723
82.2
63.8
75.0
X
11
11
84.4
72.0
IX
8101
8297
8382
66.0
VIII
7336
8734
8237
85.4
VII
7433
8122
8202
44.5
VI
4785
6954
7215
8723
Untyp.
Untyp.
FIG. 1. Representative macrorestriction patterns of unrelated isolates showing a high degree of similarity. Strains 8188 and 8362 were from different
PTHGs; strains 8382, 7215, 8237, and 6920 were all from PTHG I; strains 8735
and 5757 were from PTHG II; and strains 8184 and 8321 were from PTHG IV.
Positions of l DNA size markers are indicated on the left.
533
534
GRUNDMANN ET AL.
J. CLIN. MICROBIOL.
21. Ogle, J. W., and M. L. Vasil. 1993. Molecular approaches to the epidemiologic typing of Pseudomonas aeruginosa, p. 141150. In R. B. Fick, Jr. (ed.),
Pseudomonas aeruginosa. The opportunist. Pathogenesis and disease1993.
CRC Press, Boca Raton, Fla.
22. Ojeniyi, B., C. Wolz, G. Doring, J. Lam, V. Rosdahl, and N. Hiby. 1990.
Typing of polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients. Acta Pathol. Microbiol. Immunol. Scand. 98:423431.
23. rskov, F., and I. rskov. 1983. Summary of a workshop on the clone
concept in the epidemiology, taxonomy, and evolution of Enterobacteriaceae
and other bacteria. J. Infect. Dis. 148:346357.
24. Pier, G. D. 1985. Pulmonary disease associated with Pseudomonas aeruginosa
in cystic fibrosis: current status of host-bacterium interactions. J. Infect. Dis.
151:575580.
25. Pitt, T. L. 1988. Epidemiological typing of Pseudomonas aeruginosa. Eur. J.
Med. Microbiol. Infect. Dis. 7:238247.
26. Pradella, S., M. Pletschette, F. Mantey-Stiers, and W. Bautsch. 1994. Macrorestriction analysis of Pseudomonas aeruginosa in colonized burn patients.
Eur. J. Med. Microbiol. Infect. Dis. 13:122128.
27. Romling, U., D. Grothues, W. Bautsch, and B. Tummler. 1989. A physical
genome map of Pseudomonas aeruginosa PAO. EMBO J. 8:40814089.
28. Romling, U., J. Wingender, H. Muller, and B. Tummler. 1994. A major
Pseudomonas aeruginosa clone common to patients and aquatic habitats.
Appl. Environ. Microbiol. 60:17341738.
29. Shooter, R. A., K. A. Walker, V. R. Williams, G. M. Horgan, M. T. Parker,
E. H. Asheshov, and J. F. Baltimore. 1966. Faecal carriage of Pseudomonas
aeruginosa in hospital patients. Possible spread from patient to patient.
Lancet ii:13311337.
30. Speert, D., M. Campbell, S. Farmer, K. Volpel, A. Joffee, and W.
Paranchych. 1989. Use of a pilin gene probe to study molecular epidemiology of Pseudomonas aeruginosa. J. Clin. Microbiol. 27:25892593.
31. Struelens, M. J., V. Schwann, A. Deplano, and D. Baran. 1993. Genome
macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J. Clin. Microbiol. 31:2320
2326.
32. Stull, T. L., J. J. LiPuma, and T. D. Edlind. 1988. A broad-spectrum probe
for molecular epidemiology of bacteria: ribosomal RNA. J. Infect. Dis.
157:280286.
33. Vasil, M. L., C. Chamberlain, and C. R. Grant. 1986. Molecular studies of
Pseudomonas aeruginosa exotoxin A gene. Infect. Immun. 53:538548.
34. Vasil, M. L., J. Ogle, C. Grant, and A. Vasil. 1987. Recombinant DNA
approaches to the study of the regulation of virulence factors and epidemiology of Pseudomonas aeruginosa. Antibiot. Chemother. (Basel) 39:264278.
35. Whitby, J. L., and A. Rampling. 1972. Pseudomonas contamination in domestic and hospital environments. Lancet i:1517.